US FDA's Hiring: First Phase Of Cures Implementation Will Focus On Senior Staff
Workforce report to Congress, mandated by 21st Century Cures Act, details FDA's plans for implementing its new authorities provided by the law.
You may also be interested in...
Lauren Silvis To Depart US FDA, Adding To High-Level String Of Agency Turnover In 2019
Lauren Silvis will leave her post as chief of staff at the US FDA in the next several weeks, when she will be replaced by associate commissioner for strategic initiatives and external affairs Keagan Lenihan.
Generics Office At US FDA Could Get New Director Before Uhl Departs
Kathleen Uhl gave seven months' notice of her retirement, which may allow new director to be hired and on-boarded before she departs.
US FDA Generic Drug Office Director Uhl Announces Retirement
Uhl, who shepherded OGD into the user fee era, will retire in February.